← Back to Search

Behavioural Intervention

Guided Digital Mindfulness Programs for Brain Health (BRIGHT-Mind Trial)

N/A
Recruiting
Led By Kevin Madore, PhD
Research Sponsored by Lumos Labs, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study day 0 to study day 84
Awards & highlights

Summary

This trial looks at how digital programs can help improve mental health through improved thinking and brain changes.

Who is the study for?
This trial is for adults aged 25-80 who can use a computer with internet and video conferencing tools, understand English, and follow instructions. They must be able to see well enough (with glasses if needed) to work on a computer but cannot have had seizures or significant tics, severe mental health conditions, neurological disorders like Alzheimer's or Parkinson's, or any recent medical condition that could affect the study results. They should live independently and not be pregnant.Check my eligibility
What is being tested?
The study tests two digital programs designed to stimulate the mind. It aims to improve thinking skills and measure changes in brain structure and function through daily online activities participants complete at home using their own computers.See study design
What are the potential side effects?
Since this trial involves digital programs for cognitive stimulation rather than medication, traditional side effects are not expected. However, individuals sensitive to bright screens may experience headaches, dizziness or nausea.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study day 0 to study day 84
This trial's timeline: 3 weeks for screening, Varies for treatment, and study day 0 to study day 84 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall Composite from Creyos (formerly Cambridge Brain Sciences)
Secondary outcome measures
Concentration Domain Score from Creyos
Memory Domain Score from Creyos
Planning Domain Score from Creyos
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Cohort BExperimental Treatment2 Interventions
Remote + Imaging subjects
Group II: Cohort AExperimental Treatment2 Interventions
Remote-Only subjects

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Digital cognitive training programs enhance cognition by promoting neuroplasticity through structured, repetitive tasks that stimulate specific cognitive functions like memory and attention. This is crucial for cognition patients as it helps form new neural connections, potentially mitigating cognitive decline and improving overall cognitive performance and quality of life.

Find a Location

Who is running the clinical trial?

Lumos Labs, Inc.Lead Sponsor
14 Previous Clinical Trials
15,402 Total Patients Enrolled
Kevin Madore, PhDPrincipal InvestigatorLumos Labs, Inc.
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

Digital Program 1 (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05912556 — N/A
Cognition Research Study Groups: Cohort A, Cohort B
~417 spots leftby Jul 2025